Richard A. Miller M.D., President and CEO at Corvus Pharmaceuticals, Inc. (CRVS), bought 36,216 shares at $9.82 ($357K) on 2017-06-12, disclosed to the SEC on 2017-06-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.89 | 3,784 | $37K | 10.5% |
| 2 | $9.95 | 5,000 | $50K | 13.9% |
| 3 | $9.82 | 11,216 | $110K | 30.8% |
| 4 | $9.82 | 11,216 | $110K | 30.8% |
| 5 | $9.75 | 2,500 | $24K | 6.8% |
| 6 | $10.14 | 2,500 |
| $25K |
| 7.1% |
| Total | $9.86 avg | 36,216 | $357K | 100% |
| Filing → |
| CRVS | BUY | 2022-12-15 | $45K | — | Filing → |
| CRVS | BUY | 2022-09-28 | $19K | — | Filing → |
| CRVS | BUY | 2022-09-20 | $16K | — | Filing → |